Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hexavalent Vaccine”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Post-approval studies (Phase 4)Study completedNCT05289271
What this trial is testing

Safety, Tolerability, and Immunogenicity of Vaxelis™ in Children Previously Vaccinated With Vaxelis™ or Hexyon™ (V419-016)

Who this might be right for
Vaccines, CombinedHexavalent Vaccine
Merck Sharp & Dohme LLC 168
Large-scale testing (Phase 3)UnknownNCT03402776
What this trial is testing

Impact of a Fourth Hexavalent Vaccine After Hematopoietic Stem Cell Transplantation

Who this might be right for
Haemopoietic Stem Cell TransplantationAllograft
University Hospital, Grenoble 200
Post-approval studies (Phase 4)Not Yet RecruitingNCT06748612
What this trial is testing

Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)

Who this might be right for
Polio
International Centre for Diarrhoeal Disease Research, Bangladesh 1,190
Large-scale testing (Phase 3)Looking for participantsNCT06608199
What this trial is testing

Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine

Who this might be right for
Pneumococcal VaccinesPneumococcal Infections
Beijing Minhai Biotechnology Co., Ltd 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06611371
What this trial is testing

Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age.

Who this might be right for
Group B Streptococcal Infections
Inventprise Inc. 600
Large-scale testing (Phase 3)Study completedNCT01839175
What this trial is testing

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
Sanofi Pasteur, a Sanofi Company 350
Large-scale testing (Phase 3)Looking for participantsNCT06413121
What this trial is testing

Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV

Who this might be right for
Diptheria ImmunizationTetanus ImmunizationPertussis Immunization+3 more
Serum Institute of India Pvt. Ltd. 1,557
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06618196
What this trial is testing

Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age

Who this might be right for
DiphtheriaTetanusPertussis+3 more
LG Chem 336
Post-approval studies (Phase 4)Study completedNCT00316654
What this trial is testing

Persistence of Antibody Response to N. Meningitidis Group C in Children

Who this might be right for
Prevention of Meningococcal Infection
Novartis Vaccines 489
Large-scale testing (Phase 3)Study completedNCT02697474
What this trial is testing

Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.

Who this might be right for
Hepatitis B
Sanofi Pasteur, a Sanofi Company 150
Early research (Phase 1)UnknownNCT05952596
What this trial is testing

Evaluate Safety and Immunogenicity of APV006 in Healthy Adults

Who this might be right for
DiphtheriaTetanusPertussis+3 more
LG Chem 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT06744205
What this trial is testing

A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older

Who this might be right for
InfluenzaHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 1,162
Large-scale testing (Phase 3)Looking for participantsNCT06947499
What this trial is testing

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

Who this might be right for
DiphtheriaTetanusPertussis+3 more
LG Chem 1,186
Testing effectiveness (Phase 2)Study completedNCT00627458
What this trial is testing

Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine

Who this might be right for
Acellular PertussisDiphtheriaPoliomyelitis+3 more
GlaxoSmithKline 403
Testing effectiveness (Phase 2)Looking for participantsNCT06967272
What this trial is testing

PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)

Who this might be right for
Rotavirus Gastroenteritis
Sinovac Life Sciences Co., Ltd. 400
Not applicableStudy completedNCT02610348
What this trial is testing

Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age

Who this might be right for
Hepatitis B
Sanofi Pasteur, a Sanofi Company 122
Early research (Phase 1)Study completedNCT05968989
What this trial is testing

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT00551915
What this trial is testing

The Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003)

Who this might be right for
Bacterial Infections; Virus Diseases
Merck Sharp & Dohme LLC 756
Early research (Phase 1)Looking for participantsNCT06863142
What this trial is testing

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

Who this might be right for
Influenza PreventionSeasonal Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 45
Large-scale testing (Phase 3)Study completedNCT00310674
What this trial is testing

Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age

Who this might be right for
Prevention of Meningococcal Infection
Novartis 150
Load More Results